Intensity-Modulated Radiation Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Solid Tumors; Head and Neck Cancer Interventions: Drug: SYH2051 tablets; Radiation: Intensity-Modulated Radiation Therapy (IMRT) Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
